Cargando…
Therapeutic Effects of Silibinin Against Polycystic Ovary Syndrome Induced by Letrozole in Rats via Its Potential Anti-Inflammatory and Anti-Oxidant Activities
BACKGROUND: Current therapies for polycystic ovary syndrome (PCOS) are accompanied by unwanted effects. Silibinin; a flavonolignan has pleiotropic activities and favorable safety profile. PURPOSE: To investigate the efficacy of silibinin on estrous cyclicity, inflammation, oxidative stress and ovari...
Autores principales: | Marouf, Bushra Hassan, Ismaeel, Dana Omer, Hassan, Ali Hussein, Ali, Othman Jalal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469941/ https://www.ncbi.nlm.nih.gov/pubmed/36110507 http://dx.doi.org/10.2147/JIR.S379725 |
Ejemplares similares
-
Effect of Silibinin on Dyslipidemia and Glycemic Alteration Associated with Polycystic Ovarian Syndrome: An Experimental Study on Rats
por: Marouf, Bushra Hassan
Publicado: (2022) -
Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome
por: Hajishafiha, Masomeh, et al.
Publicado: (2013) -
Therapeutic Effect of Ecklonia cava Extract in Letrozole-Induced Polycystic Ovary Syndrome Rats
por: Yang, Hyun, et al.
Publicado: (2018) -
Letrozole for patients with polycystic ovary syndrome: A retrospective study
por: Guang, Hui-juan, et al.
Publicado: (2018) -
Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome [Erratum]
Publicado: (2017)